Annual Report

Overview

The report describes PuraPharm's 2024 consolidated revenue of HK$382.1 million and a lower financial result amid market and policy pressures. It reports total GHG emissions of 5,475 tCO2e and a target to reduce GHG emissions intensity by 20% by 2030 against 2020. The Board is identified as responsible for overall ESG management, while the workforce and safety sections report 479 employees and zero work-related fatalities for the reporting period.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2024
Period: 1 January 2024 – 31 December 2024
Publication date: 31 March 2025
Language: English
Pages
File size
Restatement: Disclosed

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services